Search Results
Apr 10, 2026, 22:00 ET Super Micro Computer, Inc. Notice of May 26, 2026 Application Deadline for Class Action Lawsuits - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
director, and Senior Vice President of Business Development), Ruei-Tsang Chang ("a general manager in the [Super Micro's] Taiwan office)," and Ting-Wei Sun ("a third-party broker and fixer"), for engaging in a "scheme to divert massive quantities of servers housing U.S. artificial intelligence technology
More news about: Kahn Swick & Foti, LLC
Apr 10, 2026, 11:39 ET SMCI UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Super Micro (SMCI) Investors of Securities Class Action Deadline on May 26, 2026
director, and Senior Vice President of Business Development), Ruei-Tsang Chang ("a general manager in the [Super Micro's] Taiwan office"), and Ting-Wei Sun (a third-party broker and "fixer") "conspired to systematically divert [Super Micro's] servers with certain GPUs to China without a license
More news about: Faruqi & Faruqi, LLP
Apr 10, 2026, 08:00 ET Vivatides Therapeutics Announces Oversubscribed $54 Million Series A Financing to Accelerate Extrahepatic RNA Therapeutics Development
accelerating the clinical translation of its pipeline, and delivering safer and more effective innovative therapies to patients worldwide."Dr. Wei Ding, Partner at Apricot Capital, commented: "As an early investor in Vivatides' seed round, we are delighted to see the company successfully complete
More news about: Vivatides Therapeutics
Apr 09, 2026, 20:00 ET AI Pioneer and Nobel Laureate Geoffrey Hinton Joins Human Longevity, Inc. Scientific Advisory Board
genomics, advanced imaging, and multi-omic biomarkers."We are deeply honored to welcome Dr. Hinton as an advisor to Human Longevity," said Dr. Wei-Wu He, Executive Chairman of HLI. "Artificial intelligence is at the core of everything we do. I firmly believe AI will transform healthcare, and Dr.
More news about: Human Longevity Inc.
Apr 09, 2026, 11:33 ET Erste Implantation des transkatheterbasierten Mitralklappensystems ProStyle M® von KingstronBio im Rahmen der nationalen multizentrischen konfirmatorischen Studie erfolgreich durchgeführt
der KingstronBio Technology (Changshu) Co., Ltd. (KingstronBio) eigenständig entwickelt. Der Eingriff wurde von Professor Wang Chunsheng und Professor Wei Lai von der Abteilung für Herzchirurgie des Zhongshan Hospital, das der Fudan University angeschlossen ist, durchgeführt und markierte den offiziellen
More news about: KingstronBio
Apr 09, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Super Micro Computer, Inc. Of Class Action Lawsuit and Upcoming Deadlines - SMCI
co-founder, director, and Senior Vice President of Business Development), Ruei-Tsang Chang ("a general manager in [Super Micro's] Taiwan office"), and Ting-Wei Sun ("a third-party broker and "'fixer'") "conspired to systematically divert [Super Micro's] servers with certain GPUs to China without a license to
More news about: Pomerantz LLP
Apr 09, 2026, 07:00 ET OncoC4 announces first participant's dosing in Phase 1/2 clinical trial of ONC-841 for the treatment of Alzheimer's disease
Xuanwu Hospital of Capital Medical University in China. The Principal Investigators for the clinical study are Professor Yi Tang and Professor Cuibai Wei at the Xuanwu Hospital."Extending our clinical study from cancer to AD showcases OncoC4's research engine and Xuanwu Hospital's infrastructure
More news about: OncoC4
Apr 09, 2026, 05:00 ET ATFX Connect Q2 2026 Institutional Edge: How Institutions Find Opportunities in Turbulent Markets
classes, highlighting the importance of execution timing and liquidity access when managing cross-asset exposure during periods of market stress.Wei Qiang Zhang, Managing Director of ATFX Connect Global, commented on the current geopolitical environment:"In times of geopolitical uncertainty
More news about: ATFX Connect
Apr 09, 2026, 01:20 ET Completado el primer implante del sistema de válvula mitral transcatéter ProStyle M® de KingstronBio
independiente por KingstronBio Technology (Changshu) Co., Ltd. (KingstronBio). El procedimiento fue realizado por el profesor Wang Chunsheng y el profesor Wei Lai del Departamento de Cirugía Cardíaca del Hospital Zhongshan, afiliado a la Universidad de Fudan, marcando así el inicio oficial del estudio clínico
More news about: KingstronBio
Apr 09, 2026, 01:04 ET First Implant of KingstronBio's ProStyle M® Transcatheter Mitral Valve System Successfully Completed in National Multicenter Confirmatory Study
independently developed by KingstronBio Technology (Changshu) Co., Ltd. (KingstronBio). The procedure was performed by Professor Wang Chunsheng and Professor Wei Lai of the Department of Cardiac Surgery, Zhongshan Hospital Affiliated to Fudan University, marking the official launch of the national multicenter
More news about: KingstronBio
Apr 09, 2026, 00:18 ET First Implant of KingstronBio's ProStyle M® Transcatheter Mitral Valve System Successfully Completed in National Multicenter Confirmatory Study
independently developed by KingstronBio Technology (Changshu) Co., Ltd. (KingstronBio). The procedure was performed by Professor Wang Chunsheng and Professor Wei Lai of the Department of Cardiac Surgery, Zhongshan Hospital Affiliated to Fudan University, marking the official launch of the national multicenter
More news about: KingstronBio
Apr 08, 2026, 15:09 ET La première implantation du système de valve mitrale transcathéter ProStyle M® de KingstronBio a été réalisée avec succès dans le cadre d'une étude nationale multicentrique de confirmation
indépendamment par KingstronBio Technology (Changshu) Co., Ltd. (KingstronBio). L'intervention a été réalisée par les professeurs Wang Chunsheng et Wei Lai du département de chirurgie cardiaque de l'hôpital Zhongshan affilié à l'université de Fudan, marquant ainsi le lancement officiel de l'étude clinique
More news about: KingstronBio
Apr 08, 2026, 12:30 ET INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Super Micro Computer, Inc. (SMCI) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
co-founder, director, and Senior Vice President of Business Development), Ruei-Tsang Chang ("a general manager in [Super Micro's] Taiwan office"), and Ting-Wei Sun ("a third-party broker and "'fixer'") "conspired to systematically divert [Super Micro's] servers with certain GPUs to China without a license to
More news about: Robbins Geller Rudman & Dowd LLP
Apr 08, 2026, 10:10 ET First Implant of KingstronBio's ProStyle M® Transcatheter Mitral Valve System Successfully Completed in National Multicenter Confirmatory Study
independently developed by KingstronBio Technology (Changshu) Co., Ltd. (KingstronBio). The procedure was performed by Professor Wang Chunsheng and Professor Wei Lai of the Department of Cardiac Surgery, Zhongshan Hospital Affiliated to Fudan University, marking the official launch of the national multicenter
More news about: KingstronBio
Apr 08, 2026, 08:00 ET Waters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV Assay
Garcia FA, Kobetz E, Partridge EE, Brandt HM et al. (2010) Cervical cancer prevention: new tools and old barriers. Cancer 116 (11): 2531-2542.Wei F, Georges D, Man I, Baussano I, Clifford GM. Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic
More news about: Waters Corporation
Apr 07, 2026, 11:04 ET Dr. Feridun Hamdullahpur, Chairman of AMTD Group, Appointed to the Global Strategic Advisory Board of HKUST (GZ)
Board is chaired by Prof. Sir Jim McDonald, Former Principal and Vice-Chancellor of The University of Strathclyde.Other members include Prof. Wei Shyy, Former President of The Hong Kong University of Science and Technology; Prof. Jacques Biot, Former President of École Polytechnique; Prof. Ningsheng
More news about: AMTD Digital; AMTD IDEA Group; The Generation Essentials Group
Apr 06, 2026, 09:00 ET Abbott recebe aprovação regulatória no Brasil de serplulimabe, novo medicamento biológico para o tratamento de câncer de pulmão de pequenas células com doença extensa, oferecendo uma nova alternativa para pacientes
YouTube.Referências:Zhang Y, Wei R, Song G, et al. Insights into the mechanisms of serplulimab: a distinctive anti-PD-1 monoclonal antibody, in combination with a TIGIT or LAG3 inhibitor
More news about: Abbott
Apr 04, 2026, 07:53 ET SMCI SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Super Micro (SMCI) Investors of Securities Class Action Deadline on May 26, 2026
director, and Senior Vice President of Business Development), Ruei-Tsang Chang ("a general manager in the [Super Micro's] Taiwan office"), and Ting-Wei Sun (a third-party broker and "fixer") "conspired to systematically divert [Super Micro's] servers with certain GPUs to China without a license
More news about: Faruqi & Faruqi, LLP
Apr 03, 2026, 22:30 ET INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Super Micro Computer, Inc. (SMCI) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
co-founder, director, and Senior Vice President of Business Development), Ruei-Tsang Chang ("a general manager in [Super Micro's] Taiwan office"), and Ting-Wei Sun ("a third-party broker and "'fixer'") "conspired to systematically divert [Super Micro's] servers with certain GPUs to China without a license to
More news about: Robbins Geller Rudman & Dowd LLP
Apr 03, 2026, 22:02 ET Super Micro Computer Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Super Micro Computer, Inc. - SMCI
director, and Senior Vice President of Business Development), Ruei-Tsang Chang ("a general manager in the [Super Micro's] Taiwan office)," and Ting-Wei Sun ("a third-party broker and fixer"), for engaging in a "scheme to divert massive quantities of servers housing U.S. artificial intelligence technology
More news about: ClaimsFiler
Apr 03, 2026, 02:54 ET Cango Inc. Tuntaskan Investasi Strategis US$65 Juta dan Raih Pendanaan US$10 Juta dari Obligasi Konversi guna Memperkuat Posisi Keuangan, serta Mendorong Ekspansi di Sektor AI dan Energi
menjual 49.242.424 saham biasa Kelas A kepada dua entitas yang masing-masing dimiliki oleh Xin Jin, Chairman, Board of Directors, dan Chang-Wei Chiu, Director. Transaksi ini diselesaikan pada 31 Maret 2026 dan menghasilkan pendanaan setara US$65,0 juta yang dibayarkan dalam USDT. Langkah
More news about: Cango Inc.
Apr 02, 2026, 11:29 ET Cango Inc. conclui investimento estratégico de US$ 65 milhões e garante financiamento de nota conversível de US$ 10 milhões para fortalecer sua posição financeira e promover a expansão em IA e energia
Classe A para duas entidades, cada uma totalmente controlada pelo Sr. Xin Jin, presidente do Conselho de Administração da empresa, e pelo Sr. Chang-Wei Chiu, diretor da empresa, respectivamente. A transação foi concluída em 31 de março de 2026, gerando recursos líquidos equivalentes a US$ 65 milhões,
More news about: Cango Inc.
Apr 02, 2026, 11:27 ET Cango Inc. completa una inversión estratégica de 65 millones de dólares y asegura un financiamiento de pagarés convertibles de 10 millones de dólares para fortalecer su posición financiera e impulsar la expansión en IA y energía
ordinarias de Clase A a dos entidades, cada una de ellas propiedad exclusiva del Sr. Xin Jin, presidente de la junta directiva de la empresa, y del Sr. Chang-Wei Chiu, director de la empresa, respectivamente. La transacción se cerró el 31 de marzo de 2026, lo cual generó ingresos netos equivalentes a 65 millones
More news about: Cango Inc.
Apr 02, 2026, 11:19 ET Cango Inc. voltooit strategische investeringen ter waarde van 65 miljoen dollar en verzekert de financiering van converteerbare leningen ter waarde van tien miljoen dollar om de financiële positie te versterken en de uitbreiding van AI en energie te stimuleren
entiteiten, die elk volledig eigendom zijn van respectievelijk de heer Xin Jin, voorzitter van de raad van bestuur van het bedrijf, en de heer Chang-Wei Chiu, een directeur van het bedrijf. De transactie werd afgesloten op 31 maart 2026 en genereerde een netto-opbrengst van 65 miljoen dollar, afgerekend
More news about: Cango Inc.
Apr 02, 2026, 11:00 ET MAMMOTION Brings iNavi™ Service to the U.S., Setting a New Standard for Hassle-Free, High-Precision Lawn Care
precision, even in difficult terrain."Consumers have been told that professional-grade results require professional-grade installation," said Jayden Wei, CEO of MAMMOTION. "With iNavi™, we're changing that expectation, delivering greater flexibility for customers with complex lawn layouts, diverse terrain
More news about: MAMMOTION